What is a Subsequent New Drug (SND) license in India?
Services
Rs1,10,077
Description
A subsequent new drug license in India is required for variations of an already approved drug, such as new dosage forms, strengths, indications, or routes of administration. Regulated by CDSCO under the Drugs and Cosmetics Rules, it ensures safety, efficacy, and quality before market approval, facilitating innovation while maintaining stringent regulatory compliance.
Saanvis
See all ads
Member since: 4 hours
User is offline
RZ 20E/ A-3, Rajnagar, Mehrauli, New Delhi-110077
You may also like...
Useful Links
Categories
Newest Listings
© 2024 ClassifiedSeo - Classified Ads & Seo Tools Website